Caribou Biosciences Inc.

NAS: CRBU

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Caribou Biosciences Inc.

Before the Bell

 --Quotes are delayed by 20 min

Feb 8, 2023, 9:09 a.m.

CRBU
/zigman2/quotes/228313444/composite

$

7.61

Change

+0.26 +3.54%

Volume

Volume 207

Quotes are delayed by 20 min

/zigman2/quotes/228313444/composite

Previous close

$ 7.35

$ 7.35

Change

-0.09 -1.21%

Day low

Day high

$7.15

$7.50

Open

52 week low

52 week high

$4.89

$13.19

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Caribou Biosciences Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 201920202021 5-year trend
Sales/Revenue --5.79M12.36M9.6M
Cost of Goods Sold (COGS) incl. D&A ----984,000
COGS excluding D&A -----
Depreciation & Amortization Expense --751,000900,000984,000
Depreciation --751,000900,000984,000
Amortization of Intangibles -----
Gross Income ----8.61M
201920202021 5-year trend
SG&A Expense --39.34M47.59M75.59M
Research & Development --23.64M34.43M52.26M
Other SG&A --15.71M13.16M-
Other Operating Expense -----
Unusual Expense ----(158,000)
EBIT after Unusual Expense ----(66.82M)
Non Operating Income/Expense --2.29M(219,000)79,000
Non-Operating Interest Income --1.05M236,000148,000
Equity in Affiliates (Pretax) -----
Interest Expense --4,00020,0008,000
Gross Interest Expense --4,00020,0008,000
Interest Capitalized -----
Pretax Income --(30.97M)(36.13M)(66.6M)
Income Tax --(7.54M)(1.82M)321,000
Income Tax - Current Domestic --(424,000)(900,000)1,000
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic --(7.11M)(919,000)320,000
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(23.43M)(34.31M)(66.92M)
Minority Interest Expense -----
Net Income --(23.43M)(34.31M)(66.92M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(23.43M)(34.31M)(66.92M)
Preferred Dividends -----
Net Income Available to Common --(23.43M)(34.31M)(66.92M)
EPS (Basic) --(0.39)(0.57)(1.11)
Basic Shares Outstanding --59.97M59.97M60.26M
EPS (Diluted) --(0.39)(0.57)(1.11)
Diluted Shares Outstanding --59.97M59.97M60.26M
EBITDA --(33.55M)(35.22M)(66M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.